Taiwo Oladapo

Array ( [id] => 9389064 [patent_doc_number] => 08685660 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-01 [patent_title] => 'Genetic alterations in isocitrate dehydrogenase and other genes in malignant glioma' [patent_app_type] => utility [patent_app_number] => 13/060191 [patent_app_country] => US [patent_app_date] => 2009-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 188 [patent_figures_cnt] => 16 [patent_no_of_words] => 20951 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13060191 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8807986 [patent_doc_number] => 08445638 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-21 [patent_title] => 'Use of a truncated eIF-5A1 polynucleotide to induce apoptosis in cancer cells' [patent_app_type] => utility [patent_app_number] => 12/552746 [patent_app_country] => US [patent_app_date] => 2009-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 62 [patent_figures_cnt] => 65 [patent_no_of_words] => 26276 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12552746 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6220610 [patent_doc_number] => 20100055705 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-04 [patent_title] => 'COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING CANCER' [patent_app_type] => utility [patent_app_number] => 12/550601 [patent_app_country] => US [patent_app_date] => 2009-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 12007 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20100055705.pdf [firstpage_image] =>[orig_patent_app_number] => 12550601 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6518559 [patent_doc_number] => 20100261778 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-14 [patent_title] => 'Tumor Suppressor Killin' [patent_app_type] => utility [patent_app_number] => 12/543213 [patent_app_country] => US [patent_app_date] => 2009-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 43294 [patent_no_of_claims] => 77 [patent_no_of_ind_claims] => 30 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20100261778.pdf [firstpage_image] =>[orig_patent_app_number] => 12543213 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5374155 [patent_doc_number] => 20090311716 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-17 [patent_title] => 'METHODS TO TREAT OR PREVENT HORMONE-RESISTANT PROSTATE CANCER USING siRNA SPECIFIC FOR PROTOCADHERIN-PC, OR OTHER INHIBITORS OF PROTOCADHERIN-PC EXPRESSION OR ACTIVITY' [patent_app_type] => utility [patent_app_number] => 12/542231 [patent_app_country] => US [patent_app_date] => 2009-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 53 [patent_figures_cnt] => 53 [patent_no_of_words] => 65203 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20090311716.pdf [firstpage_image] =>[orig_patent_app_number] => 12542231 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6174212 [patent_doc_number] => 20110177059 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-21 [patent_title] => 'PSA AND KLK2 AS THERAPEUTIC TARGETS AND MOLECULES INHIBITING PSA AND KLK2' [patent_app_type] => utility [patent_app_number] => 13/057626 [patent_app_country] => US [patent_app_date] => 2009-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 42102 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20110177059.pdf [firstpage_image] =>[orig_patent_app_number] => 13057626 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10587720 [patent_doc_number] => 09309323 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-04-12 [patent_title] => 'Methods for detecting and treating cancer' [patent_app_type] => utility [patent_app_number] => 12/508849 [patent_app_country] => US [patent_app_date] => 2009-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 14 [patent_no_of_words] => 27954 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12508849 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4490937 [patent_doc_number] => 07955597 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-06-07 [patent_title] => 'Anti-IL-6 antibodies, compositions, methods and uses' [patent_app_type] => utility [patent_app_number] => 12/507962 [patent_app_country] => US [patent_app_date] => 2009-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 10 [patent_no_of_words] => 32265 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/955/07955597.pdf [firstpage_image] =>[orig_patent_app_number] => 12507962 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5993055 [patent_doc_number] => 20110014708 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-20 [patent_title] => 'NUCLEIC ACID FOR USE IN ALGAE AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/505210 [patent_app_country] => US [patent_app_date] => 2009-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 7320 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20110014708.pdf [firstpage_image] =>[orig_patent_app_number] => 12505210 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7741050 [patent_doc_number] => 08106163 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-31 [patent_title] => 'Compositions and methods of use for therapeutic antibodies' [patent_app_type] => utility [patent_app_number] => 12/503175 [patent_app_country] => US [patent_app_date] => 2009-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 30727 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/106/08106163.pdf [firstpage_image] =>[orig_patent_app_number] => 12503175 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5315529 [patent_doc_number] => 20090280127 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-12 [patent_title] => 'MONOCLONAL ANTIBODIES FOR ENHANCING OR INHIBITING INSULIN-LIKE GROWTH FACTOR-I' [patent_app_type] => utility [patent_app_number] => 12/498719 [patent_app_country] => US [patent_app_date] => 2009-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21679 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20090280127.pdf [firstpage_image] =>[orig_patent_app_number] => 12498719 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 42853 [patent_doc_number] => 07776328 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-17 [patent_title] => 'Antibodies that bind to EphA2 and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 12/495218 [patent_app_country] => US [patent_app_date] => 2009-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 27361 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/776/07776328.pdf [firstpage_image] =>[orig_patent_app_number] => 12495218 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6110305 [patent_doc_number] => 20110189185 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-04 [patent_title] => 'Method for Predicting Responsiveness to a Treatment With an Anti-HER2 Antibody' [patent_app_type] => utility [patent_app_number] => 12/994989 [patent_app_country] => US [patent_app_date] => 2009-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7206 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0189/20110189185.pdf [firstpage_image] =>[orig_patent_app_number] => 12994989 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6425962 [patent_doc_number] => 20100151503 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-17 [patent_title] => 'METHOD OF DETECTING LIVER CANCER, DIAGNOSTIC FOR LIVER CANCER AND REMEDY FOR CANCER' [patent_app_type] => utility [patent_app_number] => 12/480465 [patent_app_country] => US [patent_app_date] => 2009-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 13245 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0151/20100151503.pdf [firstpage_image] =>[orig_patent_app_number] => 12480465 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6616671 [patent_doc_number] => 20100003257 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-07 [patent_title] => 'Diagnosis of nasopharyngeal carcinoma and suppression of nasopharyngeal carcinoma invasion' [patent_app_type] => utility [patent_app_number] => 12/455033 [patent_app_country] => US [patent_app_date] => 2009-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 16228 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20100003257.pdf [firstpage_image] =>[orig_patent_app_number] => 12455033 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5552290 [patent_doc_number] => 20090286276 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-19 [patent_title] => 'METHODS FOR PREDICTING A PATIENT\'S RESPONSE TO EGFR INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/466129 [patent_app_country] => US [patent_app_date] => 2009-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6381 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20090286276.pdf [firstpage_image] =>[orig_patent_app_number] => 12466129 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5552327 [patent_doc_number] => 20090286313 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-19 [patent_title] => 'NON-STEROIDAL ANTI-INFLAMMATORY DRUG ACTIVATED GENE WITH ANTI-TUMORIGENIC PROPERTIES' [patent_app_type] => utility [patent_app_number] => 12/463666 [patent_app_country] => US [patent_app_date] => 2009-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 16778 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20090286313.pdf [firstpage_image] =>[orig_patent_app_number] => 12463666 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5495349 [patent_doc_number] => 20090263377 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-22 [patent_title] => 'IL-32B-TARGETED DIAGNOSIS AND THERAPY' [patent_app_type] => utility [patent_app_number] => 12/420972 [patent_app_country] => US [patent_app_date] => 2009-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 28434 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20090263377.pdf [firstpage_image] =>[orig_patent_app_number] => 12420972 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6007433 [patent_doc_number] => 20110059464 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-10 [patent_title] => 'Biomarker Panel For Prediction Of Recurrent Colorectal Cancer' [patent_app_type] => utility [patent_app_number] => 12/936231 [patent_app_country] => US [patent_app_date] => 2009-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12540 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20110059464.pdf [firstpage_image] =>[orig_patent_app_number] => 12936231 [rel_patent_id] =>[rel_patent_doc_number] =>)